Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
160.4 USD | -0.03% | -0.25% | +3.50% |
09/05 | Medincell: share price rises on resumption of trading | CF |
08/05 | AbbVie Says Canadian Regulator Expands Qulipta Indication to Cover Chronic Migraine | MT |
Sales 2024 * | 54.95B 4,584B | Sales 2025 * | 57.98B 4,837B | Capitalization | 283B 23,636B |
---|---|---|---|---|---|
Net income 2024 * | 7.99B 667B | Net income 2025 * | 10.88B 907B | EV / Sales 2024 * | 6.13 x |
Net Debt 2024 * | 53.44B 4,458B | Net Debt 2025 * | 47.17B 3,935B | EV / Sales 2025 * | 5.7 x |
P/E ratio 2024 * |
31.2
x | P/E ratio 2025 * |
23.9
x | Employees | 50,000 |
Yield 2024 * |
3.85% | Yield 2025 * |
4.05% | Free-Float | 96.37% |
Latest transcript on AbbVie Inc.
1 day | -0.03% | ||
1 week | -0.25% | ||
Current month | -1.38% | ||
1 month | -5.72% | ||
3 months | -7.86% | ||
6 months | +16.20% | ||
Current year | +3.50% |
Managers | Title | Age | Since |
---|---|---|---|
Richard Gonzalez
CEO | Chief Executive Officer | 70 | 01/13/01 |
Scott Reents
DFI | Director of Finance/CFO | 57 | 01/13/01 |
Robert Michael
PSD | President | 53 | 01/12/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Roxanne Austin
BRD | Director/Board Member | 63 | 01/13/01 |
Edward Rapp
BRD | Director/Board Member | 66 | 01/13/01 |
Director/Board Member | 70 | 01/13/01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
7.12% | 0 M€ | 0.00% | - | |
6.85% | 0 M€ | +5.54% | - | |
6.26% | 13 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
08/24/08 | 160.4 | -1.29% | 5,906,701 |
07/24/07 | 162.6 | -0.11% | 5,301,668 |
06/24/06 | 162.7 | -0.65% | 5,834,562 |
03/24/03 | 163.8 | +1.85% | 5,850,102 |
02/24/02 | 160.8 | -0.56% | 5,904,251 |
Delayed Quote Nyse, May 10, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.50% | 283B | |
+32.36% | 698B | |
+26.51% | 568B | |
-4.40% | 358B | |
+19.46% | 328B | |
+16.34% | 238B | |
+6.68% | 203B | |
-9.08% | 198B | |
+8.62% | 165B | |
-2.12% | 160B |
- Stock Market
- Equities
- ABBV Stock